MEPROBAMATE SUMMARY
Meprobamate is a white powder with a characteristic odor and a bitter taste. It is slightly soluble in water, freely soluble in acetone and alcohol, and sparingly soluble in ether.
Meprobamate tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually do not require treatment with an anxiolytic.
The effectiveness of meprobamate tablets in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient.
|
NEWS HIGHLIGHTSMedia Articles Related to Meprobamate
Trial To Test Whether Behavioral Therapy Can Reduce Anxiety In Young Adolescents With Autism
Source: Anxiety / Stress News From Medical News Today [2009.10.29]
The USF Health Rothman Center for Neuropsychiatry in St. Petersburg, FL, is conducting a two-year federal trial testing the effectiveness of behavioral psychotherapy in treating anxiety among young adolescents with autism. The University of South Florida is one three sites for the $1-million study, sponsored by the National Institute of Child Health and Development (NICHD) through the American Recovery and Reinvestment Act.
Getting On 'The GABA Receptor Shuttle' To Treat Anxiety Disorders
Source: Anxiety / Stress News From Medical News Today [2009.10.24]
There are increasingly precise molecular insights into ways that stress exposure leads to fear and through which fear extinction resolves these fear states. Extinction is generally regarded as new inhibitory learning, but where the inhibition originates from remains to be determined. Gamma-aminobutyric acid (GABA), the primary inhibitory chemical messenger in the brain, seems to be very important to these processes.
Lower Rates Of Anxiety/depression And Poor Health Among People Living Near Green Space
Source: Anxiety / Stress News From Medical News Today [2009.10.16]
People living close to green space have lower rates of anxiety/depression and poor physical health than those living in concrete jungles, finds research published ahead of print in the Journal of Epidemiology and Community Health. The researchers base their findings on the health records of people registered with 195 family doctors in 95 practices across the Netherlands. Between them, the practices serve a population of almost 350,000.
Anxiety-Prone People Find Distractions Hard to Ignore
Source: MedicineNet Panic Disorder Specialty [2009.06.30]
Title: Anxiety-Prone People Find Distractions Hard to Ignore
Category: Health News
Created: 6/30/2009 7:00:00 AM
Last Editorial Review: 6/30/2009
Depression, Anxiety Bad for the Heart
Source: MedicineNet Panic Disorder Specialty [2009.06.30]
Title: Depression, Anxiety Bad for the Heart
Category: Health News
Created: 6/30/2009 7:00:00 AM
Last Editorial Review: 6/30/2009
Published Studies Related to Meprobamate
Comparative abuse liability and pharmacological effects of meprobamate, triazolam, and butabarbital. [2003.06]
Implementation of regulations to control the prescribing of benzodiazepines in New York State in 1989 resulted in a 55% decrease in benzodiazepine prescribing, with a concomitant increase in the rates of prescribing older sedative-hypnotic compounds such as butabarbital (30% increase) and meprobamate (125% increase).
|
|
|
|
Page last updated: 2009-10-29
|
